Buying a Pharmacy in Ontario

Buying a pharmacy in Ontario requires a coordinated plan for accreditation, professional management, medication inventory, patient information and payment arrangements. A strong prescription count does not establish that the buyer can operate the same business, collect the same revenue or retain the same patients after closing. Those assumptions need separate evidence.

Start by defining the acquisition: the operating assets, shares of the pharmacy corporation, the premises, or some combination. Identify who owns the dispensary equipment, who employs the team, who holds the contracts and which entity receives payer deposits. A banner name above the door may conceal several different legal relationships.

Use an Ontario business purchase checklist for the wider transaction, then add the pharmacy-specific requests below. This guide provides general information; obtain legal, accounting and pharmacy regulatory advice for the proposed transaction.

For the broader purchase process and other sectors, visit the business acquisition hub and industry guide directory.

OCP's published acquisition process treats acquiring an existing pharmacy as opening a new pharmacy and requires a new Certificate of Accreditation. Approval involves the applicant and pharmacy, including an assessment; a proposed opening date is not a guaranteed approval date. Review the College's pharmacy purchasing process before agreeing to an unconditional closing.

For a share purchase, changes within an existing operating corporation or director changes, obtain OCP confirmation of the process applicable to the exact facts. Do not assume every ownership-related event follows the same application route. Provide the proposed corporate chart, shareholdings, directors and operating entity, and confirm ownership eligibility before committing to financing.

An asset purchase can identify purchased property and assumed obligations. A share purchase leaves the operating corporation owning its assets and carrying its history. Neither structure substitutes for regulatory compliance or contract review. The asset versus share sale comparison tool can frame the commercial discussion; the pharmacy's accreditation arrangements must still be addressed specifically.

Request financial statements, tax filings, bank deposits, dispensing system reports, payer remittances and front-store sales reports for comparable periods. Reconcile prescription numbers to amounts actually collected, then separate drug acquisition costs, dispensing income, clinical services and retail margins. High drug sales can coexist with modest cash available for wages, rent and debt service.

Ask the seller to explain reversals, rejected claims, unpaid patient balances, unusual purchasing patterns and changes in prescription mix. Review public and private payer audits, recovery demands and unresolved billing questions. Determine whether rebate income and wholesaler credits are recurring, conditional, already earned or dependent on purchase commitments the buyer cannot maintain.

Look for concentration in a retirement residence, clinic relationship, specialty therapy or single prescriber. Review the underlying arrangements and their durability. Do not treat patients as contractually committed revenue. Model the cost of replacing the seller's working hours with paid pharmacist coverage, including management duties, rather than accepting an earnings adjustment that removes the seller's compensation without a replacement cost.

The designated manager is central to the operating plan. OCP describes the DM as the pharmacist designated by the owner to manage the community pharmacy, with authority and accountability over its day-to-day operation. Its medication procurement and inventory policy also addresses staff training, drug quality, storage and inventory controls. A management title on a closing document is not enough.

Confirm who will serve, whether that person has accepted, their availability and the resources needed to perform the role. Review assessment reports and outstanding corrective actions with the proposed DM. Understand which services depend on particular pharmacists, technicians, training or equipment.

Obtain employment agreements, schedules, pay records, vacation balances, benefit obligations and contractor arrangements. Ask employment counsel how service continuity, offers and termination obligations apply to the chosen structure. Budget for relief coverage and retention. If the seller remains temporarily, document duties, compensation, availability and handover milestones so the buyer does not depend on informal promises.

A computer inventory balance is a starting point, not a purchase price. Agree on a physical count, valuation method and exclusion rules before signing. Separate prescription drugs, front-store goods, supplies, customer-owned items, returns and goods held on consignment. Specify who conducts the count and how discrepancies are resolved.

Request inventory by product, quantity, acquisition cost and expiry date. Investigate slow-moving products, excessive quantities, damaged packaging, recalls, short-dated stock and refrigerated products with incomplete temperature records. Identify items that cannot be resold or returned on acceptable terms. The buyer should understand how much stock can realistically be used before expiry.

Obtain wholesaler statements and the actual credit policies. A seller's estimate of return credits is not cash unless eligibility and receipt are established. State who owns credits arising from pre-closing purchases, who submits returns and who bears rejected claims. Avoid paying twice where a credit is included in both working capital and an inventory adjustment. Assign the cost and responsibility for lawful removal of excluded stock.

For a comparison of professional services and retail stock, see the optometry practice acquisition guide. If the proposed purchase also includes a broader food-retail operation, use the grocery store acquisition guide to organize that separate inventory review.

Narcotics and other controlled substances need a documented professional handover alongside the commercial count. Health Canada's current guidance expressly addresses a transfer of ownership without a change in physical location. For a transfer when pharmacy operations cease, it says the pharmacists should sign a transfer record, complete an inventory and retain the inventory record. Check the applicable process against Health Canada's controlled substances guidance.

Have the responsible pharmacists plan the reconciliation, authorized transfer documentation and secure custody. Review previous counts, purchase and dispensing records, adjustments, destruction records and reported losses. An unexplained shortage is not simply an arithmetic adjustment to the purchase price; it requires professional investigation and any applicable reporting.

Document the time of the count, transactions occurring afterwards and who controls the safe and access credentials at each stage. Keep patient returns awaiting destruction separate from saleable stock. The agreement should allocate historical financial exposure while recognizing that private indemnities do not displace regulatory duties.

Patient information cannot be handled as an ordinary marketing list. OCP's record retention, disclosure and disposal guideline explains pharmacies' PHIPA responsibilities and states that responsibility continues until custody and control pass to a legally authorized person. Patients must retain access, and reasonable efforts must be made to provide notice of a records transfer.

Use aggregate or appropriately de-identified information for initial commercial analysis. Have privacy counsel determine the lawful basis and safeguards before any identifiable information is disclosed during diligence. A confidentiality agreement alone does not answer that question.

The transition schedule should identify the custodian, records location, transfer method, retention arrangements and responsibility for access requests. Ask the dispensing software vendor to confirm migration scope, historical records, backups and retrieval functionality. Test the plan without exposing live patient data unnecessarily. Allocate responsibility for legacy privacy incidents, outstanding access requests and permitted post-closing access by the seller. Retaining a copy for convenience requires its own lawful justification.

Prepare a consent and onboarding list covering Ontario Drug Benefit arrangements, private insurers, wholesalers, banner or franchise agreements, software, delivery providers and equipment leases. Ask each relevant counterparty what an asset sale or share ownership change requires. An account that works today may require fresh documentation, approval or settlement arrangements for the buyer.

Distinguish regulatory readiness from billing readiness. OCP's purchasing guidance also addresses ODB paperwork and opening confirmation. Obtain a practical cutover plan for claims submission, reversals, bank deposits and pre-closing receivables. Verify clinical viewer access and related agreements where used.

Review banner obligations for purchasing minimums, rebates, system charges, renovations, branding and termination payments. Identify any security interests or guarantees supporting supplier credit.

The lease should support the services and operating hours being purchased. Check assignment and change-of-control language, renewal options, permitted use, dispensary alterations, signage, delivery access and relocation rights. Begin commercial lease negotiations early enough to resolve a landlord condition without compressing the regulatory work.

The agreement should connect payment to a defined business and a workable handover. Address the following expressly:

• Conditions for the applicable OCP process, financing, landlord consent and material counterparty approvals.
• Inventory eligibility, counting procedures, price adjustments and treatment of supplier credits.
• Allocation of receivables, payer recoveries, refunds and claims reversals spanning closing.
• Representations about assessment history, billing practices, drug records, privacy incidents and disclosed liabilities.
• Responsibility for staff obligations, excluded stock, equipment liens and outstanding corrective work.
• Transition support, records custody and evidence required to release any holdback.

A seller indemnity needs practical support: clear scope, a claims process, appropriate survival terms and an assessment of whether the seller can pay. It does not prevent a regulator or payer from exercising its own rights.

Use the interactive due diligence checklist to track evidence and unresolved items. At the earlier negotiation stage, what to include in a purchase letter of intent can help establish conditional timing, access and the proposed transaction structure before substantial costs accrue.

Suppose a buyer agrees to acquire pharmacy assets based on stable annual earnings. Diligence then shows that a material wholesaler credit depends on the seller's purchasing arrangement, several expensive medications are near expiry, and a banner consent remains outstanding. The seller also works regular pharmacist shifts that the financial presentation treats as an add-back.

The buyer should rebuild the operating forecast using confirmed supply terms, realistic usable inventory and replacement staffing costs. The parties might exclude certain stock, revise the price adjustment, obtain the banner's written position and make closing conditional on the necessary approvals. These are negotiating possibilities, not guaranteed solutions.

Separately, both sides need an operational plan for payment processing and patient service during the handover. A lower headline price will not cure an inability to bill or a missing pharmacist schedule. The example illustrates why earnings diligence, professional operations and closing conditions need to be evaluated together.

Does the seller's pharmacy accreditation automatically come with the business?

Do not assume that it does. OCP publishes a new accreditation process for acquiring an existing pharmacy. Confirm the treatment of the exact proposed transaction, particularly where shares, directors or ownership interests change within an existing corporation.

Should all medication stock be included at its recorded cost?

Only if that matches the negotiated valuation and the evidence. Expiry dates, storage history, recalls, return eligibility and usable quantities can change what the buyer should pay. Controlled substances also require a separate compliance and reconciliation plan.

Can the buyer inspect identifiable patient records before signing?

Access requires a lawful basis and appropriate safeguards. Start with aggregate information and arrange a privacy review before disclosing identifiable records. The commercial need to assess goodwill does not by itself establish permission to examine patient files.

Before releasing funds, confirm the applicable accreditation steps, designated manager, staff coverage, insurance, payer arrangements and critical consents. Complete the agreed inventory and controlled-substance handovers, verify secure records access and document who handles outstanding prescriptions, deliveries, billing corrections and patient enquiries. Give each transition task an owner and a clear completion standard.

Lamba Law provides legal help with buying a business, including transaction structure, diligence and purchase agreement terms. To discuss an Ontario pharmacy acquisition and coordinate the commercial documents with the required specialist advice, contact Lamba Law.